BLOOD 润色咨询

BLOOD

出版年份:1946 年文章数:8880 投稿命中率: 开通期刊会员,数据随心看

出版周期:Weekly 自引率:7.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1236742, encodeId=63941236e4295, content=刚刚接收一篇Article。感觉真不容易!本人硕博做HBV-HCC 的,也发过几篇文章。两年前因为工作原因才接触血液病。2022-01-11投稿,2022-02-03第一次给了修回机会,三个月。三位审稿人,虽然Positive,但补了很多小鼠体内实验。2022-05-23 第二次修回,只有一位审稿人还有问题,又多向杂志申请了一个月时间,补了大量小鼠实验。2022-07-22投回。2022-08-04 接收。非常感谢副主编和三位审稿人,确实提出了很重要的问题,对文章质量的提高有了很大的帮助。BLOOD,名副其实的血液病当家杂志。感受两个字:真难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211014/4d07a2ac47344759befa282ab96f4fe4/eec488312d2746149070b3a4ec67872b.jpg, createdBy=03641833180, createdName=ms6860193281304271, createdTime=Fri Aug 05 10:18:02 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247439, encodeId=bfd7124e43986, content=象关于病理方面的新奇的病例,例如workimages in hematology,日常工作中的病例很简短,我看好多发表的,这个会多长时间有信息啊?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbd74882418, createdName=144b78d1m17暂无昵称, createdTime=Tue Sep 06 11:01:33 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236741, encodeId=aee01236e41e5, content=投稿命中率:5.0<br>经验分享:刚刚接收一篇Article。感觉真不容易!本人硕博做HBV-HCC 的,也发过几篇文章。两年前因为工作原因才接触血液病。2022-01-11投稿,2022-02-03第一次给了修回机会,三个月。三位审稿人,虽然Positive,但补了很多小鼠体内实验。2022-05-23 第二次修回,只有一位审稿人还有问题,又多向杂志申请了一个月时间,补了大量小鼠实验。2022-07-22投回。2022-08-04 接收。非常感谢副主编和三位审稿人,确实提出了很重要的问题,对文章质量的提高有了很大的帮助。BLOOD,名副其实的血液病当家杂志。感受两个字:真难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211014/4d07a2ac47344759befa282ab96f4fe4/eec488312d2746149070b3a4ec67872b.jpg, createdBy=03641833180, createdName=ms6860193281304271, createdTime=Fri Aug 05 10:16:47 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229718, encodeId=a0de1229e1843, content=2022年稿号已经排到2万……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 30 13:40:12 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088078, encodeId=181010880e8e8, content=误差线怎么计算?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088077, encodeId=047c10880e744, content=柱状图上缺少误差线怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076515, encodeId=826b10e6515e6, content=投稿命中率:5.0 | 审稿费用:75.0<br>偏重的研究方向:儿科<br>经验分享:投过去一直没动静,交了75刀审稿费后秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fde66161989, createdName=ms7000000217889416, createdTime=Fri Dec 03 10:59:34 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004464, encodeId=23991004464be, content=偏重的研究方向: 白血病 <br>经验分享:收个案吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4fd65158409, createdName=啦啦啦。。, createdTime=Sun Aug 01 20:46:41 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963703, encodeId=5911963e03df, content=投稿外审然后被拒,有的意见感觉有些片面,有的可以采纳,下次再战!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=两难不难, createdTime=Sat May 08 13:38:09 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947815, encodeId=114994e815b1, content=审稿费用:75.0<br>偏重的研究方向:儿童;组织细胞病<br>经验分享:3.10投稿,3.12显示under review,虽然很有可能会被拒,但是人要有梦想,万一实现了呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a06d2370644, createdName=122f1382m62暂无昵称, createdTime=Sat Mar 13 10:04:30 CST 2021, time=2021-03-13, status=1, ipAttribution=)]
    2022-08-05 ms6860193281304271

    刚刚接收一篇Article。感觉真不容易!本人硕博做HBV-HCC 的,也发过几篇文章。两年前因为工作原因才接触血液病。2022-01-11投稿,2022-02-03第一次给了修回机会,三个月。三位审稿人,虽然Positive,但补了很多小鼠体内实验。2022-05-23 第二次修回,只有一位审稿人还有问题,又多向杂志申请了一个月时间,补了大量小鼠实验。2022-07-22投回。2022-08-04 接收。非常感谢副主编和三位审稿人,确实提出了很重要的问题,对文章质量的提高有了很大的帮助。BLOOD,名副其实的血液病当家杂志。感受两个字:真难。

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1236742, encodeId=63941236e4295, content=刚刚接收一篇Article。感觉真不容易!本人硕博做HBV-HCC 的,也发过几篇文章。两年前因为工作原因才接触血液病。2022-01-11投稿,2022-02-03第一次给了修回机会,三个月。三位审稿人,虽然Positive,但补了很多小鼠体内实验。2022-05-23 第二次修回,只有一位审稿人还有问题,又多向杂志申请了一个月时间,补了大量小鼠实验。2022-07-22投回。2022-08-04 接收。非常感谢副主编和三位审稿人,确实提出了很重要的问题,对文章质量的提高有了很大的帮助。BLOOD,名副其实的血液病当家杂志。感受两个字:真难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211014/4d07a2ac47344759befa282ab96f4fe4/eec488312d2746149070b3a4ec67872b.jpg, createdBy=03641833180, createdName=ms6860193281304271, createdTime=Fri Aug 05 10:18:02 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247439, encodeId=bfd7124e43986, content=象关于病理方面的新奇的病例,例如workimages in hematology,日常工作中的病例很简短,我看好多发表的,这个会多长时间有信息啊?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbd74882418, createdName=144b78d1m17暂无昵称, createdTime=Tue Sep 06 11:01:33 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236741, encodeId=aee01236e41e5, content=投稿命中率:5.0<br>经验分享:刚刚接收一篇Article。感觉真不容易!本人硕博做HBV-HCC 的,也发过几篇文章。两年前因为工作原因才接触血液病。2022-01-11投稿,2022-02-03第一次给了修回机会,三个月。三位审稿人,虽然Positive,但补了很多小鼠体内实验。2022-05-23 第二次修回,只有一位审稿人还有问题,又多向杂志申请了一个月时间,补了大量小鼠实验。2022-07-22投回。2022-08-04 接收。非常感谢副主编和三位审稿人,确实提出了很重要的问题,对文章质量的提高有了很大的帮助。BLOOD,名副其实的血液病当家杂志。感受两个字:真难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211014/4d07a2ac47344759befa282ab96f4fe4/eec488312d2746149070b3a4ec67872b.jpg, createdBy=03641833180, createdName=ms6860193281304271, createdTime=Fri Aug 05 10:16:47 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229718, encodeId=a0de1229e1843, content=2022年稿号已经排到2万……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 30 13:40:12 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088078, encodeId=181010880e8e8, content=误差线怎么计算?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088077, encodeId=047c10880e744, content=柱状图上缺少误差线怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076515, encodeId=826b10e6515e6, content=投稿命中率:5.0 | 审稿费用:75.0<br>偏重的研究方向:儿科<br>经验分享:投过去一直没动静,交了75刀审稿费后秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fde66161989, createdName=ms7000000217889416, createdTime=Fri Dec 03 10:59:34 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004464, encodeId=23991004464be, content=偏重的研究方向: 白血病 <br>经验分享:收个案吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4fd65158409, createdName=啦啦啦。。, createdTime=Sun Aug 01 20:46:41 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963703, encodeId=5911963e03df, content=投稿外审然后被拒,有的意见感觉有些片面,有的可以采纳,下次再战!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=两难不难, createdTime=Sat May 08 13:38:09 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947815, encodeId=114994e815b1, content=审稿费用:75.0<br>偏重的研究方向:儿童;组织细胞病<br>经验分享:3.10投稿,3.12显示under review,虽然很有可能会被拒,但是人要有梦想,万一实现了呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a06d2370644, createdName=122f1382m62暂无昵称, createdTime=Sat Mar 13 10:04:30 CST 2021, time=2021-03-13, status=1, ipAttribution=)]
    2022-09-06 144b78d1m17暂无昵称

    象关于病理方面的新奇的病例,例如workimages in hematology,日常工作中的病例很简短,我看好多发表的,这个会多长时间有信息啊?

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1236742, encodeId=63941236e4295, content=刚刚接收一篇Article。感觉真不容易!本人硕博做HBV-HCC 的,也发过几篇文章。两年前因为工作原因才接触血液病。2022-01-11投稿,2022-02-03第一次给了修回机会,三个月。三位审稿人,虽然Positive,但补了很多小鼠体内实验。2022-05-23 第二次修回,只有一位审稿人还有问题,又多向杂志申请了一个月时间,补了大量小鼠实验。2022-07-22投回。2022-08-04 接收。非常感谢副主编和三位审稿人,确实提出了很重要的问题,对文章质量的提高有了很大的帮助。BLOOD,名副其实的血液病当家杂志。感受两个字:真难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211014/4d07a2ac47344759befa282ab96f4fe4/eec488312d2746149070b3a4ec67872b.jpg, createdBy=03641833180, createdName=ms6860193281304271, createdTime=Fri Aug 05 10:18:02 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247439, encodeId=bfd7124e43986, content=象关于病理方面的新奇的病例,例如workimages in hematology,日常工作中的病例很简短,我看好多发表的,这个会多长时间有信息啊?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbd74882418, createdName=144b78d1m17暂无昵称, createdTime=Tue Sep 06 11:01:33 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236741, encodeId=aee01236e41e5, content=投稿命中率:5.0<br>经验分享:刚刚接收一篇Article。感觉真不容易!本人硕博做HBV-HCC 的,也发过几篇文章。两年前因为工作原因才接触血液病。2022-01-11投稿,2022-02-03第一次给了修回机会,三个月。三位审稿人,虽然Positive,但补了很多小鼠体内实验。2022-05-23 第二次修回,只有一位审稿人还有问题,又多向杂志申请了一个月时间,补了大量小鼠实验。2022-07-22投回。2022-08-04 接收。非常感谢副主编和三位审稿人,确实提出了很重要的问题,对文章质量的提高有了很大的帮助。BLOOD,名副其实的血液病当家杂志。感受两个字:真难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211014/4d07a2ac47344759befa282ab96f4fe4/eec488312d2746149070b3a4ec67872b.jpg, createdBy=03641833180, createdName=ms6860193281304271, createdTime=Fri Aug 05 10:16:47 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229718, encodeId=a0de1229e1843, content=2022年稿号已经排到2万……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 30 13:40:12 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088078, encodeId=181010880e8e8, content=误差线怎么计算?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088077, encodeId=047c10880e744, content=柱状图上缺少误差线怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076515, encodeId=826b10e6515e6, content=投稿命中率:5.0 | 审稿费用:75.0<br>偏重的研究方向:儿科<br>经验分享:投过去一直没动静,交了75刀审稿费后秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fde66161989, createdName=ms7000000217889416, createdTime=Fri Dec 03 10:59:34 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004464, encodeId=23991004464be, content=偏重的研究方向: 白血病 <br>经验分享:收个案吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4fd65158409, createdName=啦啦啦。。, createdTime=Sun Aug 01 20:46:41 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963703, encodeId=5911963e03df, content=投稿外审然后被拒,有的意见感觉有些片面,有的可以采纳,下次再战!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=两难不难, createdTime=Sat May 08 13:38:09 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947815, encodeId=114994e815b1, content=审稿费用:75.0<br>偏重的研究方向:儿童;组织细胞病<br>经验分享:3.10投稿,3.12显示under review,虽然很有可能会被拒,但是人要有梦想,万一实现了呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a06d2370644, createdName=122f1382m62暂无昵称, createdTime=Sat Mar 13 10:04:30 CST 2021, time=2021-03-13, status=1, ipAttribution=)]
    2022-08-05 ms6860193281304271

    投稿命中率:5.0
    经验分享:刚刚接收一篇Article。感觉真不容易!本人硕博做HBV-HCC 的,也发过几篇文章。两年前因为工作原因才接触血液病。2022-01-11投稿,2022-02-03第一次给了修回机会,三个月。三位审稿人,虽然Positive,但补了很多小鼠体内实验。2022-05-23 第二次修回,只有一位审稿人还有问题,又多向杂志申请了一个月时间,补了大量小鼠实验。2022-07-22投回。2022-08-04 接收。非常感谢副主编和三位审稿人,确实提出了很重要的问题,对文章质量的提高有了很大的帮助。BLOOD,名副其实的血液病当家杂志。感受两个字:真难。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1236742, encodeId=63941236e4295, content=刚刚接收一篇Article。感觉真不容易!本人硕博做HBV-HCC 的,也发过几篇文章。两年前因为工作原因才接触血液病。2022-01-11投稿,2022-02-03第一次给了修回机会,三个月。三位审稿人,虽然Positive,但补了很多小鼠体内实验。2022-05-23 第二次修回,只有一位审稿人还有问题,又多向杂志申请了一个月时间,补了大量小鼠实验。2022-07-22投回。2022-08-04 接收。非常感谢副主编和三位审稿人,确实提出了很重要的问题,对文章质量的提高有了很大的帮助。BLOOD,名副其实的血液病当家杂志。感受两个字:真难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211014/4d07a2ac47344759befa282ab96f4fe4/eec488312d2746149070b3a4ec67872b.jpg, createdBy=03641833180, createdName=ms6860193281304271, createdTime=Fri Aug 05 10:18:02 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247439, encodeId=bfd7124e43986, content=象关于病理方面的新奇的病例,例如workimages in hematology,日常工作中的病例很简短,我看好多发表的,这个会多长时间有信息啊?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbd74882418, createdName=144b78d1m17暂无昵称, createdTime=Tue Sep 06 11:01:33 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236741, encodeId=aee01236e41e5, content=投稿命中率:5.0<br>经验分享:刚刚接收一篇Article。感觉真不容易!本人硕博做HBV-HCC 的,也发过几篇文章。两年前因为工作原因才接触血液病。2022-01-11投稿,2022-02-03第一次给了修回机会,三个月。三位审稿人,虽然Positive,但补了很多小鼠体内实验。2022-05-23 第二次修回,只有一位审稿人还有问题,又多向杂志申请了一个月时间,补了大量小鼠实验。2022-07-22投回。2022-08-04 接收。非常感谢副主编和三位审稿人,确实提出了很重要的问题,对文章质量的提高有了很大的帮助。BLOOD,名副其实的血液病当家杂志。感受两个字:真难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211014/4d07a2ac47344759befa282ab96f4fe4/eec488312d2746149070b3a4ec67872b.jpg, createdBy=03641833180, createdName=ms6860193281304271, createdTime=Fri Aug 05 10:16:47 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229718, encodeId=a0de1229e1843, content=2022年稿号已经排到2万……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 30 13:40:12 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088078, encodeId=181010880e8e8, content=误差线怎么计算?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088077, encodeId=047c10880e744, content=柱状图上缺少误差线怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076515, encodeId=826b10e6515e6, content=投稿命中率:5.0 | 审稿费用:75.0<br>偏重的研究方向:儿科<br>经验分享:投过去一直没动静,交了75刀审稿费后秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fde66161989, createdName=ms7000000217889416, createdTime=Fri Dec 03 10:59:34 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004464, encodeId=23991004464be, content=偏重的研究方向: 白血病 <br>经验分享:收个案吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4fd65158409, createdName=啦啦啦。。, createdTime=Sun Aug 01 20:46:41 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963703, encodeId=5911963e03df, content=投稿外审然后被拒,有的意见感觉有些片面,有的可以采纳,下次再战!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=两难不难, createdTime=Sat May 08 13:38:09 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947815, encodeId=114994e815b1, content=审稿费用:75.0<br>偏重的研究方向:儿童;组织细胞病<br>经验分享:3.10投稿,3.12显示under review,虽然很有可能会被拒,但是人要有梦想,万一实现了呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a06d2370644, createdName=122f1382m62暂无昵称, createdTime=Sat Mar 13 10:04:30 CST 2021, time=2021-03-13, status=1, ipAttribution=)]
    2022-06-30 osmataku

    2022年稿号已经排到2万……

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1236742, encodeId=63941236e4295, content=刚刚接收一篇Article。感觉真不容易!本人硕博做HBV-HCC 的,也发过几篇文章。两年前因为工作原因才接触血液病。2022-01-11投稿,2022-02-03第一次给了修回机会,三个月。三位审稿人,虽然Positive,但补了很多小鼠体内实验。2022-05-23 第二次修回,只有一位审稿人还有问题,又多向杂志申请了一个月时间,补了大量小鼠实验。2022-07-22投回。2022-08-04 接收。非常感谢副主编和三位审稿人,确实提出了很重要的问题,对文章质量的提高有了很大的帮助。BLOOD,名副其实的血液病当家杂志。感受两个字:真难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211014/4d07a2ac47344759befa282ab96f4fe4/eec488312d2746149070b3a4ec67872b.jpg, createdBy=03641833180, createdName=ms6860193281304271, createdTime=Fri Aug 05 10:18:02 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247439, encodeId=bfd7124e43986, content=象关于病理方面的新奇的病例,例如workimages in hematology,日常工作中的病例很简短,我看好多发表的,这个会多长时间有信息啊?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbd74882418, createdName=144b78d1m17暂无昵称, createdTime=Tue Sep 06 11:01:33 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236741, encodeId=aee01236e41e5, content=投稿命中率:5.0<br>经验分享:刚刚接收一篇Article。感觉真不容易!本人硕博做HBV-HCC 的,也发过几篇文章。两年前因为工作原因才接触血液病。2022-01-11投稿,2022-02-03第一次给了修回机会,三个月。三位审稿人,虽然Positive,但补了很多小鼠体内实验。2022-05-23 第二次修回,只有一位审稿人还有问题,又多向杂志申请了一个月时间,补了大量小鼠实验。2022-07-22投回。2022-08-04 接收。非常感谢副主编和三位审稿人,确实提出了很重要的问题,对文章质量的提高有了很大的帮助。BLOOD,名副其实的血液病当家杂志。感受两个字:真难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211014/4d07a2ac47344759befa282ab96f4fe4/eec488312d2746149070b3a4ec67872b.jpg, createdBy=03641833180, createdName=ms6860193281304271, createdTime=Fri Aug 05 10:16:47 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229718, encodeId=a0de1229e1843, content=2022年稿号已经排到2万……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 30 13:40:12 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088078, encodeId=181010880e8e8, content=误差线怎么计算?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088077, encodeId=047c10880e744, content=柱状图上缺少误差线怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076515, encodeId=826b10e6515e6, content=投稿命中率:5.0 | 审稿费用:75.0<br>偏重的研究方向:儿科<br>经验分享:投过去一直没动静,交了75刀审稿费后秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fde66161989, createdName=ms7000000217889416, createdTime=Fri Dec 03 10:59:34 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004464, encodeId=23991004464be, content=偏重的研究方向: 白血病 <br>经验分享:收个案吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4fd65158409, createdName=啦啦啦。。, createdTime=Sun Aug 01 20:46:41 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963703, encodeId=5911963e03df, content=投稿外审然后被拒,有的意见感觉有些片面,有的可以采纳,下次再战!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=两难不难, createdTime=Sat May 08 13:38:09 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947815, encodeId=114994e815b1, content=审稿费用:75.0<br>偏重的研究方向:儿童;组织细胞病<br>经验分享:3.10投稿,3.12显示under review,虽然很有可能会被拒,但是人要有梦想,万一实现了呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a06d2370644, createdName=122f1382m62暂无昵称, createdTime=Sat Mar 13 10:04:30 CST 2021, time=2021-03-13, status=1, ipAttribution=)]
    2021-12-27 乌云背后的幸福线

    误差线怎么计算?

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1236742, encodeId=63941236e4295, content=刚刚接收一篇Article。感觉真不容易!本人硕博做HBV-HCC 的,也发过几篇文章。两年前因为工作原因才接触血液病。2022-01-11投稿,2022-02-03第一次给了修回机会,三个月。三位审稿人,虽然Positive,但补了很多小鼠体内实验。2022-05-23 第二次修回,只有一位审稿人还有问题,又多向杂志申请了一个月时间,补了大量小鼠实验。2022-07-22投回。2022-08-04 接收。非常感谢副主编和三位审稿人,确实提出了很重要的问题,对文章质量的提高有了很大的帮助。BLOOD,名副其实的血液病当家杂志。感受两个字:真难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211014/4d07a2ac47344759befa282ab96f4fe4/eec488312d2746149070b3a4ec67872b.jpg, createdBy=03641833180, createdName=ms6860193281304271, createdTime=Fri Aug 05 10:18:02 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247439, encodeId=bfd7124e43986, content=象关于病理方面的新奇的病例,例如workimages in hematology,日常工作中的病例很简短,我看好多发表的,这个会多长时间有信息啊?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbd74882418, createdName=144b78d1m17暂无昵称, createdTime=Tue Sep 06 11:01:33 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236741, encodeId=aee01236e41e5, content=投稿命中率:5.0<br>经验分享:刚刚接收一篇Article。感觉真不容易!本人硕博做HBV-HCC 的,也发过几篇文章。两年前因为工作原因才接触血液病。2022-01-11投稿,2022-02-03第一次给了修回机会,三个月。三位审稿人,虽然Positive,但补了很多小鼠体内实验。2022-05-23 第二次修回,只有一位审稿人还有问题,又多向杂志申请了一个月时间,补了大量小鼠实验。2022-07-22投回。2022-08-04 接收。非常感谢副主编和三位审稿人,确实提出了很重要的问题,对文章质量的提高有了很大的帮助。BLOOD,名副其实的血液病当家杂志。感受两个字:真难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211014/4d07a2ac47344759befa282ab96f4fe4/eec488312d2746149070b3a4ec67872b.jpg, createdBy=03641833180, createdName=ms6860193281304271, createdTime=Fri Aug 05 10:16:47 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229718, encodeId=a0de1229e1843, content=2022年稿号已经排到2万……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 30 13:40:12 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088078, encodeId=181010880e8e8, content=误差线怎么计算?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088077, encodeId=047c10880e744, content=柱状图上缺少误差线怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076515, encodeId=826b10e6515e6, content=投稿命中率:5.0 | 审稿费用:75.0<br>偏重的研究方向:儿科<br>经验分享:投过去一直没动静,交了75刀审稿费后秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fde66161989, createdName=ms7000000217889416, createdTime=Fri Dec 03 10:59:34 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004464, encodeId=23991004464be, content=偏重的研究方向: 白血病 <br>经验分享:收个案吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4fd65158409, createdName=啦啦啦。。, createdTime=Sun Aug 01 20:46:41 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963703, encodeId=5911963e03df, content=投稿外审然后被拒,有的意见感觉有些片面,有的可以采纳,下次再战!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=两难不难, createdTime=Sat May 08 13:38:09 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947815, encodeId=114994e815b1, content=审稿费用:75.0<br>偏重的研究方向:儿童;组织细胞病<br>经验分享:3.10投稿,3.12显示under review,虽然很有可能会被拒,但是人要有梦想,万一实现了呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a06d2370644, createdName=122f1382m62暂无昵称, createdTime=Sat Mar 13 10:04:30 CST 2021, time=2021-03-13, status=1, ipAttribution=)]
    2021-12-27 学医的彭于晏

    柱状图上缺少误差线怎么办?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1236742, encodeId=63941236e4295, content=刚刚接收一篇Article。感觉真不容易!本人硕博做HBV-HCC 的,也发过几篇文章。两年前因为工作原因才接触血液病。2022-01-11投稿,2022-02-03第一次给了修回机会,三个月。三位审稿人,虽然Positive,但补了很多小鼠体内实验。2022-05-23 第二次修回,只有一位审稿人还有问题,又多向杂志申请了一个月时间,补了大量小鼠实验。2022-07-22投回。2022-08-04 接收。非常感谢副主编和三位审稿人,确实提出了很重要的问题,对文章质量的提高有了很大的帮助。BLOOD,名副其实的血液病当家杂志。感受两个字:真难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211014/4d07a2ac47344759befa282ab96f4fe4/eec488312d2746149070b3a4ec67872b.jpg, createdBy=03641833180, createdName=ms6860193281304271, createdTime=Fri Aug 05 10:18:02 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247439, encodeId=bfd7124e43986, content=象关于病理方面的新奇的病例,例如workimages in hematology,日常工作中的病例很简短,我看好多发表的,这个会多长时间有信息啊?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbd74882418, createdName=144b78d1m17暂无昵称, createdTime=Tue Sep 06 11:01:33 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236741, encodeId=aee01236e41e5, content=投稿命中率:5.0<br>经验分享:刚刚接收一篇Article。感觉真不容易!本人硕博做HBV-HCC 的,也发过几篇文章。两年前因为工作原因才接触血液病。2022-01-11投稿,2022-02-03第一次给了修回机会,三个月。三位审稿人,虽然Positive,但补了很多小鼠体内实验。2022-05-23 第二次修回,只有一位审稿人还有问题,又多向杂志申请了一个月时间,补了大量小鼠实验。2022-07-22投回。2022-08-04 接收。非常感谢副主编和三位审稿人,确实提出了很重要的问题,对文章质量的提高有了很大的帮助。BLOOD,名副其实的血液病当家杂志。感受两个字:真难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211014/4d07a2ac47344759befa282ab96f4fe4/eec488312d2746149070b3a4ec67872b.jpg, createdBy=03641833180, createdName=ms6860193281304271, createdTime=Fri Aug 05 10:16:47 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229718, encodeId=a0de1229e1843, content=2022年稿号已经排到2万……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 30 13:40:12 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088078, encodeId=181010880e8e8, content=误差线怎么计算?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088077, encodeId=047c10880e744, content=柱状图上缺少误差线怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076515, encodeId=826b10e6515e6, content=投稿命中率:5.0 | 审稿费用:75.0<br>偏重的研究方向:儿科<br>经验分享:投过去一直没动静,交了75刀审稿费后秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fde66161989, createdName=ms7000000217889416, createdTime=Fri Dec 03 10:59:34 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004464, encodeId=23991004464be, content=偏重的研究方向: 白血病 <br>经验分享:收个案吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4fd65158409, createdName=啦啦啦。。, createdTime=Sun Aug 01 20:46:41 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963703, encodeId=5911963e03df, content=投稿外审然后被拒,有的意见感觉有些片面,有的可以采纳,下次再战!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=两难不难, createdTime=Sat May 08 13:38:09 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947815, encodeId=114994e815b1, content=审稿费用:75.0<br>偏重的研究方向:儿童;组织细胞病<br>经验分享:3.10投稿,3.12显示under review,虽然很有可能会被拒,但是人要有梦想,万一实现了呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a06d2370644, createdName=122f1382m62暂无昵称, createdTime=Sat Mar 13 10:04:30 CST 2021, time=2021-03-13, status=1, ipAttribution=)]
    2021-12-03 ms7000000217889416

    投稿命中率:5.0 | 审稿费用:75.0
    偏重的研究方向:儿科
    经验分享:投过去一直没动静,交了75刀审稿费后秒拒

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1236742, encodeId=63941236e4295, content=刚刚接收一篇Article。感觉真不容易!本人硕博做HBV-HCC 的,也发过几篇文章。两年前因为工作原因才接触血液病。2022-01-11投稿,2022-02-03第一次给了修回机会,三个月。三位审稿人,虽然Positive,但补了很多小鼠体内实验。2022-05-23 第二次修回,只有一位审稿人还有问题,又多向杂志申请了一个月时间,补了大量小鼠实验。2022-07-22投回。2022-08-04 接收。非常感谢副主编和三位审稿人,确实提出了很重要的问题,对文章质量的提高有了很大的帮助。BLOOD,名副其实的血液病当家杂志。感受两个字:真难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211014/4d07a2ac47344759befa282ab96f4fe4/eec488312d2746149070b3a4ec67872b.jpg, createdBy=03641833180, createdName=ms6860193281304271, createdTime=Fri Aug 05 10:18:02 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247439, encodeId=bfd7124e43986, content=象关于病理方面的新奇的病例,例如workimages in hematology,日常工作中的病例很简短,我看好多发表的,这个会多长时间有信息啊?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbd74882418, createdName=144b78d1m17暂无昵称, createdTime=Tue Sep 06 11:01:33 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236741, encodeId=aee01236e41e5, content=投稿命中率:5.0<br>经验分享:刚刚接收一篇Article。感觉真不容易!本人硕博做HBV-HCC 的,也发过几篇文章。两年前因为工作原因才接触血液病。2022-01-11投稿,2022-02-03第一次给了修回机会,三个月。三位审稿人,虽然Positive,但补了很多小鼠体内实验。2022-05-23 第二次修回,只有一位审稿人还有问题,又多向杂志申请了一个月时间,补了大量小鼠实验。2022-07-22投回。2022-08-04 接收。非常感谢副主编和三位审稿人,确实提出了很重要的问题,对文章质量的提高有了很大的帮助。BLOOD,名副其实的血液病当家杂志。感受两个字:真难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211014/4d07a2ac47344759befa282ab96f4fe4/eec488312d2746149070b3a4ec67872b.jpg, createdBy=03641833180, createdName=ms6860193281304271, createdTime=Fri Aug 05 10:16:47 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229718, encodeId=a0de1229e1843, content=2022年稿号已经排到2万……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 30 13:40:12 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088078, encodeId=181010880e8e8, content=误差线怎么计算?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088077, encodeId=047c10880e744, content=柱状图上缺少误差线怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076515, encodeId=826b10e6515e6, content=投稿命中率:5.0 | 审稿费用:75.0<br>偏重的研究方向:儿科<br>经验分享:投过去一直没动静,交了75刀审稿费后秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fde66161989, createdName=ms7000000217889416, createdTime=Fri Dec 03 10:59:34 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004464, encodeId=23991004464be, content=偏重的研究方向: 白血病 <br>经验分享:收个案吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4fd65158409, createdName=啦啦啦。。, createdTime=Sun Aug 01 20:46:41 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963703, encodeId=5911963e03df, content=投稿外审然后被拒,有的意见感觉有些片面,有的可以采纳,下次再战!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=两难不难, createdTime=Sat May 08 13:38:09 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947815, encodeId=114994e815b1, content=审稿费用:75.0<br>偏重的研究方向:儿童;组织细胞病<br>经验分享:3.10投稿,3.12显示under review,虽然很有可能会被拒,但是人要有梦想,万一实现了呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a06d2370644, createdName=122f1382m62暂无昵称, createdTime=Sat Mar 13 10:04:30 CST 2021, time=2021-03-13, status=1, ipAttribution=)]
    2021-08-01 啦啦啦。。

    偏重的研究方向: 白血病
    经验分享:收个案吗

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1236742, encodeId=63941236e4295, content=刚刚接收一篇Article。感觉真不容易!本人硕博做HBV-HCC 的,也发过几篇文章。两年前因为工作原因才接触血液病。2022-01-11投稿,2022-02-03第一次给了修回机会,三个月。三位审稿人,虽然Positive,但补了很多小鼠体内实验。2022-05-23 第二次修回,只有一位审稿人还有问题,又多向杂志申请了一个月时间,补了大量小鼠实验。2022-07-22投回。2022-08-04 接收。非常感谢副主编和三位审稿人,确实提出了很重要的问题,对文章质量的提高有了很大的帮助。BLOOD,名副其实的血液病当家杂志。感受两个字:真难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211014/4d07a2ac47344759befa282ab96f4fe4/eec488312d2746149070b3a4ec67872b.jpg, createdBy=03641833180, createdName=ms6860193281304271, createdTime=Fri Aug 05 10:18:02 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247439, encodeId=bfd7124e43986, content=象关于病理方面的新奇的病例,例如workimages in hematology,日常工作中的病例很简短,我看好多发表的,这个会多长时间有信息啊?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbd74882418, createdName=144b78d1m17暂无昵称, createdTime=Tue Sep 06 11:01:33 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236741, encodeId=aee01236e41e5, content=投稿命中率:5.0<br>经验分享:刚刚接收一篇Article。感觉真不容易!本人硕博做HBV-HCC 的,也发过几篇文章。两年前因为工作原因才接触血液病。2022-01-11投稿,2022-02-03第一次给了修回机会,三个月。三位审稿人,虽然Positive,但补了很多小鼠体内实验。2022-05-23 第二次修回,只有一位审稿人还有问题,又多向杂志申请了一个月时间,补了大量小鼠实验。2022-07-22投回。2022-08-04 接收。非常感谢副主编和三位审稿人,确实提出了很重要的问题,对文章质量的提高有了很大的帮助。BLOOD,名副其实的血液病当家杂志。感受两个字:真难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211014/4d07a2ac47344759befa282ab96f4fe4/eec488312d2746149070b3a4ec67872b.jpg, createdBy=03641833180, createdName=ms6860193281304271, createdTime=Fri Aug 05 10:16:47 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229718, encodeId=a0de1229e1843, content=2022年稿号已经排到2万……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 30 13:40:12 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088078, encodeId=181010880e8e8, content=误差线怎么计算?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088077, encodeId=047c10880e744, content=柱状图上缺少误差线怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076515, encodeId=826b10e6515e6, content=投稿命中率:5.0 | 审稿费用:75.0<br>偏重的研究方向:儿科<br>经验分享:投过去一直没动静,交了75刀审稿费后秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fde66161989, createdName=ms7000000217889416, createdTime=Fri Dec 03 10:59:34 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004464, encodeId=23991004464be, content=偏重的研究方向: 白血病 <br>经验分享:收个案吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4fd65158409, createdName=啦啦啦。。, createdTime=Sun Aug 01 20:46:41 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963703, encodeId=5911963e03df, content=投稿外审然后被拒,有的意见感觉有些片面,有的可以采纳,下次再战!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=两难不难, createdTime=Sat May 08 13:38:09 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947815, encodeId=114994e815b1, content=审稿费用:75.0<br>偏重的研究方向:儿童;组织细胞病<br>经验分享:3.10投稿,3.12显示under review,虽然很有可能会被拒,但是人要有梦想,万一实现了呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a06d2370644, createdName=122f1382m62暂无昵称, createdTime=Sat Mar 13 10:04:30 CST 2021, time=2021-03-13, status=1, ipAttribution=)]
    2021-05-08 两难不难

    投稿外审然后被拒,有的意见感觉有些片面,有的可以采纳,下次再战!

    6

    展开6条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1236742, encodeId=63941236e4295, content=刚刚接收一篇Article。感觉真不容易!本人硕博做HBV-HCC 的,也发过几篇文章。两年前因为工作原因才接触血液病。2022-01-11投稿,2022-02-03第一次给了修回机会,三个月。三位审稿人,虽然Positive,但补了很多小鼠体内实验。2022-05-23 第二次修回,只有一位审稿人还有问题,又多向杂志申请了一个月时间,补了大量小鼠实验。2022-07-22投回。2022-08-04 接收。非常感谢副主编和三位审稿人,确实提出了很重要的问题,对文章质量的提高有了很大的帮助。BLOOD,名副其实的血液病当家杂志。感受两个字:真难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211014/4d07a2ac47344759befa282ab96f4fe4/eec488312d2746149070b3a4ec67872b.jpg, createdBy=03641833180, createdName=ms6860193281304271, createdTime=Fri Aug 05 10:18:02 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1247439, encodeId=bfd7124e43986, content=象关于病理方面的新奇的病例,例如workimages in hematology,日常工作中的病例很简短,我看好多发表的,这个会多长时间有信息啊?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbd74882418, createdName=144b78d1m17暂无昵称, createdTime=Tue Sep 06 11:01:33 CST 2022, time=2022-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236741, encodeId=aee01236e41e5, content=投稿命中率:5.0<br>经验分享:刚刚接收一篇Article。感觉真不容易!本人硕博做HBV-HCC 的,也发过几篇文章。两年前因为工作原因才接触血液病。2022-01-11投稿,2022-02-03第一次给了修回机会,三个月。三位审稿人,虽然Positive,但补了很多小鼠体内实验。2022-05-23 第二次修回,只有一位审稿人还有问题,又多向杂志申请了一个月时间,补了大量小鼠实验。2022-07-22投回。2022-08-04 接收。非常感谢副主编和三位审稿人,确实提出了很重要的问题,对文章质量的提高有了很大的帮助。BLOOD,名副其实的血液病当家杂志。感受两个字:真难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211014/4d07a2ac47344759befa282ab96f4fe4/eec488312d2746149070b3a4ec67872b.jpg, createdBy=03641833180, createdName=ms6860193281304271, createdTime=Fri Aug 05 10:16:47 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229718, encodeId=a0de1229e1843, content=2022年稿号已经排到2万……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 30 13:40:12 CST 2022, time=2022-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088078, encodeId=181010880e8e8, content=误差线怎么计算?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088077, encodeId=047c10880e744, content=柱状图上缺少误差线怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=284, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076515, encodeId=826b10e6515e6, content=投稿命中率:5.0 | 审稿费用:75.0<br>偏重的研究方向:儿科<br>经验分享:投过去一直没动静,交了75刀审稿费后秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=304, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fde66161989, createdName=ms7000000217889416, createdTime=Fri Dec 03 10:59:34 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004464, encodeId=23991004464be, content=偏重的研究方向: 白血病 <br>经验分享:收个案吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=343, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4fd65158409, createdName=啦啦啦。。, createdTime=Sun Aug 01 20:46:41 CST 2021, time=2021-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=963703, encodeId=5911963e03df, content=投稿外审然后被拒,有的意见感觉有些片面,有的可以采纳,下次再战!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=两难不难, createdTime=Sat May 08 13:38:09 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947815, encodeId=114994e815b1, content=审稿费用:75.0<br>偏重的研究方向:儿童;组织细胞病<br>经验分享:3.10投稿,3.12显示under review,虽然很有可能会被拒,但是人要有梦想,万一实现了呢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a06d2370644, createdName=122f1382m62暂无昵称, createdTime=Sat Mar 13 10:04:30 CST 2021, time=2021-03-13, status=1, ipAttribution=)]
    2021-03-13 122f1382m62暂无昵称

    审稿费用:75.0
    偏重的研究方向:儿童;组织细胞病
    经验分享:3.10投稿,3.12显示under review,虽然很有可能会被拒,但是人要有梦想,万一实现了呢?

    5

    展开5条回复
共70条页码: 1/7页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分